Interleukin-5 in the Pathophysiology of Severe Asthma.

IL-5 T2-high asthma benralizumab eosinophils mepolizumab reslizumab

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2019
Historique:
received: 01 10 2019
accepted: 02 12 2019
entrez: 11 1 2020
pubmed: 11 1 2020
medline: 11 1 2020
Statut: epublish

Résumé

Interleukin-5 (IL-5) exerts a central pathogenic role in differentiation, recruitment, survival, and degranulation of eosinophils. Indeed, during the last years, significant advances have been made in our understanding of the cellular and molecular mechanisms underlying the powerful actions of IL-5 finalized to the induction, maintenance, and amplification of eosinophilic inflammation. Therefore, IL-5 is a suitable target for add-on biological therapies based on either IL-5 inhibition (mepolizumab, reslizumab) or blockade of its receptor (benralizumab). These modern treatments can result in being definitely beneficial for patients with severe type 2 (T2)-high eosinophilic asthma, refractory to conventional anti-inflammatory drugs such as inhaled and even systemic corticosteroids.

Identifiants

pubmed: 31920718
doi: 10.3389/fphys.2019.01514
pmc: PMC6927944
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1514

Informations de copyright

Copyright © 2019 Pelaia, Paoletti, Puggioni, Racca, Pelaia, Canonica and Heffler.

Références

Immunol Cell Biol. 2007 Jul;85(5):348-56
pubmed: 17325694
Expert Rev Clin Immunol. 2018 Sep;14(9):731-737
pubmed: 30107759
Int Immunol. 1999 Dec;11(12):1935-44
pubmed: 10590259
Front Med (Lausanne). 2017 Jul 11;4:101
pubmed: 28744457
Trends Immunol. 2004 Sep;25(9):477-82
pubmed: 15324740
Eur Respir J. 2017 Jun 29;49(6):
pubmed: 28663322
Eur J Pharmacol. 2000 Oct 20;406(3):325-32
pubmed: 11040338
Immunity. 1996 Jan;4(1):15-24
pubmed: 8574848
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1403-9
pubmed: 11704586
Hum Antibodies. 2009;18(1-2):17-27
pubmed: 19478395
J Biol Chem. 1995 Apr 21;270(16):9459-71
pubmed: 7721873
Curr Pharm Des. 2002;8(20):1837-44
pubmed: 12171535
N Engl J Med. 2017 Jun 22;376(25):2448-2458
pubmed: 28530840
Nat Rev Immunol. 2013 Feb;13(2):75-87
pubmed: 23292121
Ther Adv Respir Dis. 2017 Jan;11(1):40-45
pubmed: 27856823
Int Immunol. 2009 Dec;21(12):1303-9
pubmed: 19819937
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1125-32
pubmed: 21852542
Curr Opin Mol Ther. 2003 Jun;5(3):321-5
pubmed: 12870444
J Allergy Clin Immunol. 1993 Oct;92(4):607-15
pubmed: 8409120
Am J Respir Crit Care Med. 1995 Aug;152(2):467-72
pubmed: 7633694
Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):373-378
pubmed: 31135395
J Investig Allergol Clin Immunol. 2019 Apr;29(2):84-93
pubmed: 31017107
J Allergy Clin Immunol. 2001 Aug;108(2):250-7
pubmed: 11496242
Lancet Respir Med. 2017 May;5(5):390-400
pubmed: 28395936
Ther Clin Risk Manag. 2016 Jul 01;12:1075-82
pubmed: 27445482
Respir Res. 2001;2(2):71-9
pubmed: 11686868
Pulm Pharmacol Ther. 2017 Apr;43:39-45
pubmed: 28159511
J Interferon Cytokine Res. 2004 May;24(5):271-81
pubmed: 15153310
Vitam Horm. 2006;74:1-30
pubmed: 17027509
Immunopharmacol Immunotoxicol. 2005;27(3):371-93
pubmed: 16237950
World Allergy Organ J. 2018 Dec 6;11(1):34
pubmed: 30555618
Thorax. 1953 Sep;8(3):207-13
pubmed: 13102418
J Clin Invest. 2004 Feb;113(4):551-60
pubmed: 14966564
Curr Pharm Des. 2008;14(12):1231-9
pubmed: 18473871
Biomed Res Int. 2018 May 10;2018:4839230
pubmed: 29862274
J Clin Invest. 1999 Sep;104(5):657-67
pubmed: 10487780
Arzneimittelforschung. 1999 Sep;49(9):779-90
pubmed: 10514907
Front Med (Lausanne). 2017 Jul 18;4:106
pubmed: 28770202
Am J Respir Cell Mol Biol. 2004 Jul;31(1):62-8
pubmed: 14975941
N Engl J Med. 2009 Mar 5;360(10):985-93
pubmed: 19264687
Mediators Inflamm. 2015;2015:879783
pubmed: 25878402
Clin Exp Allergy. 2012 May;42(5):712-37
pubmed: 22092535
Ann Allergy Asthma Immunol. 2019 Apr;122(4):367-372
pubmed: 30703438
J Allergy Clin Immunol. 2016 Jan;137(1):75-86.e8
pubmed: 26194544
J Allergy Clin Immunol. 2010 Jun;125(6):1344-1353.e2
pubmed: 20513525
N Engl J Med. 2014 Sep 25;371(13):1198-207
pubmed: 25199059
Blood. 2015 Jun 18;125(25):3896-904
pubmed: 25862560
J Exp Med. 1998 Aug 3;188(3):421-9
pubmed: 9687520
Front Med (Lausanne). 2017 Aug 31;4:135
pubmed: 28913336
Am J Respir Crit Care Med. 2002 Sep 15;166(6):883-9
pubmed: 12231502
Immunol Rev. 2012 Nov;250(1):277-302
pubmed: 23046136
Biomed Res Int. 2018 Oct 25;2018:7582057
pubmed: 30498762
Int Arch Allergy Immunol. 1994 Sep;105(1):83-90
pubmed: 8086833
J Biol Chem. 2000 Apr 14;275(15):10968-75
pubmed: 10753897
Respir Med. 2014 Dec;108(12):1723-32
pubmed: 25456708
Immunity. 2019 Apr 16;50(4):975-991
pubmed: 30995510
Front Immunol. 2017 Mar 10;8:242
pubmed: 28344579
J Biol Chem. 2004 Mar 5;279(10):9547-56
pubmed: 14662768
Medicina (Kaunas). 2019 Apr 05;55(4):null
pubmed: 30959833
Am J Respir Crit Care Med. 2009 Sep 1;180(5):388-95
pubmed: 19483109
Eur J Biochem. 1994 Oct 15;225(2):635-40
pubmed: 7957178
N Engl J Med. 2014 Sep 25;371(13):1189-97
pubmed: 25199060
Cell Tissue Res. 2010 Sep;341(3):405-15
pubmed: 20686785
Am J Respir Crit Care Med. 2019 Feb 15;199(4):433-445
pubmed: 30525902
Pulm Pharmacol Ther. 2019 Oct;58:101830
pubmed: 31344472
Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1623-7
pubmed: 7504892
Blood. 2000 Apr 15;95(8):2491-8
pubmed: 10753826
Lancet Respir Med. 2019 Jan;7(1):46-59
pubmed: 30416083
Respir Med. 2007 Jul;101(7):1447-54
pubmed: 17379492
Lancet. 2012 Aug 18;380(9842):651-9
pubmed: 22901886
Lancet Respir Med. 2015 May;3(5):355-66
pubmed: 25736990
Am J Respir Cell Mol Biol. 1995 Mar;12(3):320-8
pubmed: 7873198
Curr Opin Immunol. 2008 Jun;20(3):288-94
pubmed: 18511250
J Immunol. 1995 Jul 1;155(1):397-402
pubmed: 7602114
Ann Allergy Asthma Immunol. 2018 May;120(5):504-511.e4
pubmed: 29409951
Immunol Allergy Clin North Am. 2018 Nov;38(4):639-654
pubmed: 30342585
Front Med (Lausanne). 2017 Jul 24;4:103
pubmed: 28791287
Biologics. 2017 Jun 27;11:81-95
pubmed: 28721009
J Immunol. 2004 Nov 15;173(10):6409-17
pubmed: 15528381
Front Med (Lausanne). 2017 Jun 12;4:75
pubmed: 28660189
Drug Des Devel Ther. 2018 Mar 21;12:619-628
pubmed: 29606855
Nat Immunol. 2015 Jan;16(1):45-56
pubmed: 25521684
Am J Respir Cell Mol Biol. 1995 Sep;13(3):360-5
pubmed: 7654390
Am J Respir Crit Care Med. 2019 Apr 1;199(7):823-829
pubmed: 30726120
Am J Physiol. 1996 Mar;270(3 Pt 1):L368-75
pubmed: 8638729
Nat Med. 2013 Aug;19(8):977-9
pubmed: 23921745
Am J Respir Cell Mol Biol. 2005 Jul;33(1):65-70
pubmed: 15802551
Lancet. 2016 Oct 29;388(10056):2115-2127
pubmed: 27609408
Nat Rev Drug Discov. 2013 Feb;12(2):117-29
pubmed: 23334207
Pulm Pharmacol Ther. 2018 Dec;53:1-5
pubmed: 30217438
Curr Opin Allergy Clin Immunol. 2016 Apr;16(2):186-200
pubmed: 26859368
Immunotherapy. 2016;8(1):27-34
pubmed: 26653083
J Cell Physiol. 2005 Mar;202(3):642-53
pubmed: 15316926
N Engl J Med. 2009 Mar 5;360(10):973-84
pubmed: 19264686
J Clin Invest. 2003 Oct;112(7):1029-36
pubmed: 14523040
Expert Opin Biol Ther. 2012 Jan;12(1):113-8
pubmed: 22136436
J Exp Med. 1996 Jan 1;183(1):195-201
pubmed: 8551223
Am J Respir Crit Care Med. 2004 Mar 1;169(5):573-7
pubmed: 14630618
Am J Respir Crit Care Med. 2003 Jun 15;167(12):1655-9
pubmed: 12649124
Lancet. 2016 Oct 29;388(10056):2128-2141
pubmed: 27609406
Lancet Respir Med. 2017 Jul;5(7):568-576
pubmed: 28545978
Cytokine. 2017 Oct;98:59-70
pubmed: 28863833
J Allergy Clin Immunol. 2010 Jul;126(1):16-25; quiz 26-7
pubmed: 20434203
N Engl J Med. 1990 Oct 11;323(15):1033-9
pubmed: 2215562
Biomed Res Int. 2018 Nov 5;2018:5698212
pubmed: 30519580
J Cell Death. 2014 Feb 10;7:1-9
pubmed: 25278781
Int Arch Allergy Immunol. 2003 Aug;131(4):283-90
pubmed: 12915771
Curr Opin Allergy Clin Immunol. 2015 Aug;15(4):392-6
pubmed: 26110690
Cytokine Growth Factor Rev. 2019 Jun;47:83-98
pubmed: 31126874
J Biol Chem. 2002 Jul 26;277(30):26733-40
pubmed: 11986321
Nat Rev Dis Primers. 2015 Sep 10;1:15025
pubmed: 27189668
J Immunol. 2000 Aug 15;165(4):2198-204
pubmed: 10925307
Am J Physiol. 1998 Sep;275(3):C623-33
pubmed: 9730944
Clin Exp Allergy. 2008 May;38(5):709-50
pubmed: 18384431
Drug Des Devel Ther. 2017 Oct 30;11:3137-3144
pubmed: 29133975
J Immunol. 2007 Sep 15;179(6):3452-62
pubmed: 17785779
Expert Rev Clin Immunol. 2016 Sep;12(9):903-5
pubmed: 27450970
Chest. 2016 Oct;150(4):789-798
pubmed: 27056586

Auteurs

Corrado Pelaia (C)

Department of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.

Giovanni Paoletti (G)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Francesca Puggioni (F)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Francesca Racca (F)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Girolamo Pelaia (G)

Department of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.

Giorgio Walter Canonica (GW)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Enrico Heffler (E)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Classifications MeSH